745. Surveillance for Oseltamivir-Resistant Influenza A(H1N1)pdm09 Virus Infections During 2016–2017 and 2017–2018, United States

BACKGROUND: Three neuraminidase inhibitors (NAIs) are approved and recommended for treatment of influenza in the United States; however, antiviral resistance can emerge during or after treatment, and sporadic resistant viruses unrelated to NAI exposure may occur, especially in influenza A(H1N1)pdm09...

Descripción completa

Detalles Bibliográficos
Autores principales: Spencer, Sarah, Nguyen, Ha, Elal, Anwar Abd, Laplante, Jennifer, George, Kirsten St, Fry, Alicia M, Gubareva, Larisa, Campbell, Angela P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255555/
http://dx.doi.org/10.1093/ofid/ofy210.752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255555/
http://dx.doi.org/10.1093/ofid/ofy210.752

Ejemplares similares